Detail of the session
Type :
DISCUSSED E-POSTERS
DISCUSSED E-POSTERS
Date :
Saturday 27th April 2019
Saturday 27th April 2019
Schedule :
10h10 - 10h25
10h10 - 10h25
Session Title :
E-Posters Discussion - Counter 1
Room :
E-POSTERS' AREA
P066
10h10 - 10h15
10h10 - 10h15
EXPOSURE-EFFICACY RESPONSE MODELLING OF BMS-986165, A SELECTIVE ORAL TYROSINE KINASE 2 (TYK2) INHIBITOR, IN A PHASE 2 STUDY IN PSORIASIS
Ihab GIRGIS - United States
Ihab GIRGIS - United States
P067
10h15 - 10h20
10h15 - 10h20
THE EFFECT OF GUSELKUMAB ON PSORIASIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 2 STUDY
Alice GOTTLIEB - United States
Alice GOTTLIEB - United States
P068
10h20 - 10h25
10h20 - 10h25
SHORT- AND LONG-TERM SAFETY OF RISANKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS: AN INTEGRATED ANALYSIS
Hervé BACHELEZ - France
Hervé BACHELEZ - France